Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss

BACKGROUND: Recent studies indicate that glucagon-like peptide (GLP)-1 inhibits appetite in part through regulation of soluble leptin receptors. Thus, during weight loss maintenance, GLP-1 receptor agonist (GLP-1RA) administration may inhibit weight loss-induced increases in soluble leptin receptors...

Descripción completa

Detalles Bibliográficos
Autores principales: Iepsen, E W, Lundgren, J, Dirksen, C, Jensen, J-EB, Pedersen, O, Hansen, T, Madsbad, S, Holst, J J, Torekov, S S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424381/
https://www.ncbi.nlm.nih.gov/pubmed/25287751
http://dx.doi.org/10.1038/ijo.2014.177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424381/
https://www.ncbi.nlm.nih.gov/pubmed/25287751
http://dx.doi.org/10.1038/ijo.2014.177

Ejemplares similares